| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |